| 2016 updated EULAR evidence-based recommendations for the management of gout P Richette, M Doherty, E Pascual, V Barskova, F Becce, ... Annals of the Rheumatic Diseases 76 (1), 29-42, 2017 | 1790 | 2017 |
| 2018 updated European League Against Rheumatism evidence-based recommendations for the diagnosis of gout P Richette, M Doherty, E Pascual, V Barskova, F Becce, J Castaneda, ... Annals of the rheumatic diseases 79 (1), 31-38, 2020 | 363 | 2020 |
| Self-controlled designs in pharmacoepidemiology involving electronic healthcare databases: a systematic review N Gault, J Castañeda-Sanabria, Y De Rycke, S Guillo, S Foulon, ... BMC Medical Research Methodology 17 (1), 25, 2017 | 58 | 2017 |
| Users of biologics in clinical practice: would they be eligible for phase III clinical studies? Cohort Study in the French Psoriasis Registry PSOBIOTEQ M Masson Regnault, J Castañeda‐Sanabria, MHT Diep Tran, ... Journal of the European Academy of Dermatology and Venereology 34 (2), 293-300, 2020 | 43 | 2020 |
| Off-label use of the expensive orphan drug eculizumab in France 2009–2013 and the impact of literature: focus on the transplantation field J Castañeda-Sanabria, D Hajage, M Le Jouan, A Perozziello, F Tubach European journal of clinical pharmacology 72, 737-746, 2016 | 16 | 2016 |
| Risk of malignancy in rheumatoid arthritis patients initiating biologics: an historical propensity score matched cohort study within the French nationwide healthcare database R Seror, A Lafourcade, Y De Rycke, S Pinto, J Castaneda, B Fautrel, ... RMD open 8 (2), e002139, 2022 | 11 | 2022 |
| Underuse of self‐controlled designs in pharmacoepidemiology in electronic healthcare databases: a systematic review N Gault, J Castañeda‐Sanabria, S Guillo, S Foulon, F Tubach Pharmacoepidemiology and drug safety 25 (4), 372-377, 2016 | 8 | 2016 |
| Tendances temporelles de l’utilisation hors indications de l’autorisation de mise sur le marche (AMM) de l’éculizumab (SOLIRIS®) et étude de l’impact des publications J Castaneda, F Tubach, D Hajage, A Perozziello, JC Buzi Revue d'Épidémiologie et de Santé Publique 63, S46, 2015 | 1 | 2015 |
| Farmacoterapia del Trastorno Afectivo Bipolar: Nuevos Descubrimientos Fisiopatológicos, Evidencia Clínica y Búsqueda de Nuevos Estabilizadores del Ánimo JAC Sanabria, JCM Loaiza, MCG Guevara | | |
